{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:06:39Z","timestamp":1790190399001,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Failure of conventional clinical therapies such as tumor resection and chemotherapy are mainly due to the ineffective control of tumor metastasis. Metastasis consists of three steps: (i) tumor cells extravasate from the primary sites into the circulation system via epithelial-mesenchymal transition (EMT), (ii) the circulating tumor cells (CTCs) form \u201cmicro-thrombi\u201d with platelets to evade the immune surveillance in circulation, and (iii) the CTCs colonize in the pre-metastatic niche. Here, we design a systemic metastasis-targeted nanotherapeutic (H@CaPP) composed of an anti-inflammatory agent, piceatannol, and an anti-thrombotic agent, low molecular weight heparin, to hinder the multiple steps of tumor metastasis. H@CaPP is found efficiently impeded EMT, inhibited the formation of \u201cmicro-thrombi\u201d, and prevented the development of pre-metastatic niche. When combined with surgical resection or chemotherapy, H@CaPP efficiently inhibits tumor metastasis and prolonged overall survival of tumor-bearing mice. Collectively, we provide a simple and effective systemic metastasis-targeted nanotherapeutic for combating tumor metastasis.<\/jats:p>","DOI":"10.1038\/s41467-021-23466-5","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T10:12:23Z","timestamp":1622110343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy"],"prefix":"10.1038","volume":"12","author":[{"given":"Minjun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6789-3059","authenticated-orcid":false,"given":"Xiaoling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1330-9616","authenticated-orcid":false,"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"23466_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan, L., Pantel, K. & Kang, Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med. 19, 1450\u20131464 (2013).","journal-title":"Nat. Med."},{"key":"23466_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrc1886","volume":"6","author":"P Mehlen","year":"2006","unstructured":"Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449\u2013458 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"23466_CR3","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","volume":"369","author":"SA Eccles","year":"2007","unstructured":"Eccles, S. A. & Welch, D. R. Metastasis: recent discoveries and novel treatment strategies. Lancet 369, 1742\u20131757 (2007).","journal-title":"Lancet"},{"key":"23466_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-319-16366-6_6","volume":"862","author":"BP Schneider","year":"2015","unstructured":"Schneider, B. P., Hershman, D. L. & Loprinzi, C. Symptoms: chemotherapy-induced peripheral neuropathy. Adv. Exp. Med. Biol. 862, 77\u201387 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"23466_CR5","doi-asserted-by":"publisher","first-page":"4047617","DOI":"10.1155\/2019\/4047617","volume":"2019","author":"DM Byrnes","year":"2019","unstructured":"Byrnes, D. M. et al. Complications of intrathecal chemotherapy in adults: single-institution experience in 109 consecutive patients. J. Oncol. 2019, 4047617 (2019).","journal-title":"J. Oncol."},{"key":"23466_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10585-017-9870-x","volume":"35","author":"GS Karagiannis","year":"2018","unstructured":"Karagiannis, G. S., Condeelis, J. S. & Oktay, M. H. Chemotherapy-induced metastasis: mechanisms and translational opportunities. Clin. Exp. Metastasis 35, 269\u2013284 (2018).","journal-title":"Clin. Exp. Metastasis"},{"key":"23466_CR7","doi-asserted-by":"crossref","unstructured":"Anderson, R. L. et al. A framework for the development of effective anti-metastatic agents. Nat. Rev. Clin. Oncol. 16, 185\u2013204 (2018).","DOI":"10.1038\/s41571-018-0134-8"},{"key":"23466_CR8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc3628","volume":"13","author":"N Reymond","year":"2013","unstructured":"Reymond, N., d\u2019Agua, B. B. & Ridley, A. J. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 13, 858\u2013870 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"23466_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"23466_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1878-0261.12017","volume":"11","author":"KT Yeung","year":"2017","unstructured":"Yeung, K. T. & Yang, J. Epithelial-mesenchymal transition in tumor metastasis. Mol. Oncol. 11, 28\u201339 (2017).","journal-title":"Mol. Oncol."},{"key":"23466_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ccr.2009.03.016","volume":"15","author":"Y Wu","year":"2009","unstructured":"Wu, Y. et al. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416\u2013428 (2009).","journal-title":"Cancer Cell"},{"key":"23466_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349\u2013361 (2012).","journal-title":"Cell"},{"key":"23466_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","volume":"11","author":"T Kang","year":"2017","unstructured":"Kang, T. et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano 11, 1397\u20131411 (2017).","journal-title":"ACS Nano"},{"key":"23466_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.10.033","volume":"113","author":"J Yao","year":"2017","unstructured":"Yao, J. et al. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer. Biomaterials 113, 1\u201317 (2017).","journal-title":"Biomaterials"},{"key":"23466_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay, L. J. & Felding-Habermann, B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11, 123\u2013134 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"23466_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V. & Sood, A. K. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell 33, 965\u2013983 (2018).","journal-title":"Cancer Cell"},{"key":"23466_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massague","year":"2016","unstructured":"Massague, J. & Obenauf, A. C. Metastatic colonization by circulating tumour cells. Nature 529, 298\u2013306 (2016).","journal-title":"Nature"},{"key":"23466_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. & Cao, X. Characteristics and significance of the pre-metastatic niche. Cancer Cell 30, 668\u2013681 (2016).","journal-title":"Cancer Cell"},{"key":"23466_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302\u2013317 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"23466_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1021\/acs.nanolett.9b03883","volume":"20","author":"Y Long","year":"2020","unstructured":"Long, Y. et al. Self-delivery micellar nanoparticles prevent premetastatic niche formation by interfering with the early recruitment and vascular destruction of granulocytic myeloid-derived suppressor cells. Nano Lett. 20, 2219\u20132229 (2020).","journal-title":"Nano Lett."},{"key":"23466_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ccell.2017.01.007","volume":"31","author":"E Wieland","year":"2017","unstructured":"Wieland, E. et al. Endothelial Notch1 activity facilitates metastasis. Cancer Cell 31, 355\u2013367 (2017).","journal-title":"Cancer Cell"},{"key":"23466_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10585-007-9098-2","volume":"25","author":"FL Miles","year":"2008","unstructured":"Miles, F. L., Pruitt, F. L., van Golen, K. L. & Cooper, C. R. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin. Exp. Metastasis 25, 305\u2013324 (2008).","journal-title":"Clin. Exp. Metastasis"},{"key":"23466_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1535-6108(02)00153-8","volume":"2","author":"S Hiratsuka","year":"2002","unstructured":"Hiratsuka, S. et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289\u2013300 (2002).","journal-title":"Cancer Cell"},{"key":"23466_CR24","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1002\/jps.24186","volume":"103","author":"T Zong","year":"2014","unstructured":"Zong, T. et al. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT. J. Pharm. Sci. 103, 3891\u20133901 (2014).","journal-title":"J. Pharm. Sci."},{"key":"23466_CR25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/ncb1794","volume":"10","author":"S Hiratsuka","year":"2008","unstructured":"Hiratsuka, S. et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349\u20131355 (2008).","journal-title":"Nat. Cell Biol."},{"key":"23466_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc2868","volume":"10","author":"AS Chung","year":"2010","unstructured":"Chung, A. S., Lee, J. & Ferrara, N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat. Rev. Cancer 10, 505\u2013514 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"23466_CR27","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Activated platelets-targeting micelles with controlled drug release for effective treatment of primary and metastatic triple negative breast cancer.\u00a0Adv. Funct. Mater.\u00a029, 1806620 (2019).","DOI":"10.1002\/adfm.201806620"},{"key":"23466_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jconrel.2020.06.037","volume":"325","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., Han, M. & Gao, J. Prognosis and targeting of pre-metastatic niche. J. Control. Release 325, 223\u2013234 (2020).","journal-title":"J. Control. Release"},{"key":"23466_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.phrs.2017.08.002","volume":"124","author":"M Dvorakova","year":"2017","unstructured":"Dvorakova, M. & Landa, P. Anti-inflammatory activity of natural stilbenoids: a review. Pharmacol. Res. 124, 126\u2013145 (2017).","journal-title":"Pharmacol. Res."},{"key":"23466_CR30","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1021\/acs.jafc.7b01567","volume":"65","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Inhibitory effect of piceatannol on TNF-alpha-mediated inflammation and insulin resistance in 3T3-L1 adipocytes. J. Agric. Food Chem. 65, 4634\u20134641 (2017).","journal-title":"J. Agric. Food Chem."},{"key":"23466_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7150\/thno.29137","volume":"9","author":"Q Yu","year":"2019","unstructured":"Yu, Q. et al. Chemotherapy priming of the pancreatic tumor microenvironment promotes delivery and anti-metastasis efficacy of intravenous low-molecular-weight heparin-coated lipid-siRNA complex. Theranostics 9, 355\u2013368 (2019).","journal-title":"Theranostics"},{"key":"23466_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7150\/thno.29026","volume":"9","author":"C Xia","year":"2019","unstructured":"Xia, C. et al. Low molecular weight heparin-coated and dendrimer-based core-shell nanoplatform with enhanced immune activation and multiple anti-metastatic effects for melanoma treatment. Theranostics 9, 337\u2013354 (2019).","journal-title":"Theranostics"},{"key":"23466_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2017.08.024","volume":"264","author":"Y He","year":"2017","unstructured":"He, Y. et al. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer. J. Control. Release 264, 76\u201388 (2017).","journal-title":"J. Control. Release"},{"key":"23466_CR34","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/acsnano.7b01522","volume":"11","author":"K Hu","year":"2017","unstructured":"Hu, K. et al. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano 11, 4916\u20134925 (2017).","journal-title":"ACS Nano"},{"key":"23466_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.02.033","volume":"164","author":"T Kang","year":"2018","unstructured":"Kang, T. et al. Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality. Biomaterials 164, 80\u201397 (2018).","journal-title":"Biomaterials"},{"key":"23466_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14425-7","volume":"11","author":"Y Huang","year":"2020","unstructured":"Huang, Y. et al. Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors. Nat. Commun. 11, 622 (2020).","journal-title":"Nat. Commun."},{"key":"23466_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/mt.2011.270","volume":"20","author":"Y Yang","year":"2012","unstructured":"Yang, Y., Li, J., Liu, F. & Huang, L. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis. Mol. Ther. 20, 609\u2013615 (2012).","journal-title":"Mol. Ther."},{"key":"23466_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.7150\/thno.14689","volume":"6","author":"AB Satterlee","year":"2016","unstructured":"Satterlee, A. B. & Huang, L. Current and future theranostic applications of the lipid-calcium-phosphate nanoparticle platform. Theranostics 6, 918\u2013929 (2016).","journal-title":"Theranostics"},{"key":"23466_CR39","doi-asserted-by":"publisher","first-page":"119232","DOI":"10.1016\/j.biomaterials.2019.119232","volume":"216","author":"J Tang","year":"2019","unstructured":"Tang, J. et al. Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy. Biomaterials 216, 119232 (2019).","journal-title":"Biomaterials"},{"key":"23466_CR40","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1039\/C6NR04034A","volume":"8","author":"C Qiu","year":"2016","unstructured":"Qiu, C. et al. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy. Nanoscale 8, 13033\u201313044 (2016).","journal-title":"Nanoscale"},{"key":"23466_CR41","doi-asserted-by":"publisher","first-page":"e1900631","DOI":"10.1002\/smll.201900631","volume":"15","author":"Y Pei","year":"2019","unstructured":"Pei, Y. et al. Sequential targeting TGF-\u03b2 signaling and KRAS mutation increases therapeutic efficacy in pancreatic cancer. Small 15, e1900631 (2019).","journal-title":"Small"},{"key":"23466_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15144","volume":"8","author":"JL Huang","year":"2017","unstructured":"Huang, J. L. et al. Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis. Nat. Commun. 8, 15144 (2017).","journal-title":"Nat. Commun."},{"key":"23466_CR43","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","volume":"32","author":"J Guo","year":"2011","unstructured":"Guo, J. et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32, 8010\u20138020 (2011).","journal-title":"Biomaterials"},{"key":"23466_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.ijpharm.2015.10.081","volume":"496","author":"N Ma","year":"2015","unstructured":"Ma, N. et al. Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery. Int J. Pharm. 496, 984\u2013992 (2015).","journal-title":"Int J. Pharm."},{"key":"23466_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2018.08.004","volume":"182","author":"J Yang","year":"2018","unstructured":"Yang, J. et al. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance. Biomaterials 182, 145\u2013156 (2018).","journal-title":"Biomaterials"},{"key":"23466_CR46","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820\u2013827 (2005).","journal-title":"Nature"},{"key":"23466_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10735-015-9633-4","volume":"46","author":"Y Ye","year":"2015","unstructured":"Ye, Y., Liu, S., Wu, C. & Sun, Z. TGFbeta modulates inflammatory cytokines and growth factors to create premetastatic microenvironment and stimulate lung metastasis. J. Mol. Histol. 46, 365\u2013375 (2015).","journal-title":"J. Mol. Histol."},{"key":"23466_CR48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ajpath.2012.10.026","volume":"182","author":"H Amano","year":"2013","unstructured":"Amano, H. et al. Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells. Am. J. Pathol. 182, 553\u2013564 (2013).","journal-title":"Am. J. Pathol."},{"key":"23466_CR49","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1158\/0008-5472.CAN-03-1054","volume":"64","author":"RJ Ludwig","year":"2004","unstructured":"Ludwig, R. J. et al. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res. 64, 2743\u20132750 (2004).","journal-title":"Cancer Res."},{"key":"23466_CR50","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1182\/blood-2008-04-153866","volume":"112","author":"A Shigeta","year":"2008","unstructured":"Shigeta, A. et al. An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation. Blood 112, 4915\u20134923 (2008).","journal-title":"Blood"},{"key":"23466_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1021\/acs.molpharmaceut.6b00979","volume":"14","author":"L Mei","year":"2017","unstructured":"Mei, L. et al. Polymer-drug nanoparticles combine doxorubicin carrier and heparin bioactivity functionalities for primary and metastatic cancer treatment. Mol. Pharm. 14, 513\u2013522 (2017).","journal-title":"Mol. Pharm."},{"key":"23466_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-bioeng-061008-124949","volume":"11","author":"K Konstantopoulos","year":"2009","unstructured":"Konstantopoulos, K. & Thomas, S. N. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev. Biomed. Eng. 11, 177\u2013202 (2009).","journal-title":"Annu Rev. Biomed. Eng."},{"key":"23466_CR53","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrm2871","volume":"11","author":"SJ Shattil","year":"2010","unstructured":"Shattil, S. J., Kim, C. & Ginsberg, M. H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 11, 288\u2013300 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"23466_CR54","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","volume":"72","author":"T Placke","year":"2012","unstructured":"Placke, T. et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 72, 440\u2013448 (2012).","journal-title":"Cancer Res."},{"key":"23466_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","volume":"105","author":"JS Palumbo","year":"2005","unstructured":"Palumbo, J. S. et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105, 178\u2013185 (2005).","journal-title":"Blood"},{"key":"23466_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/pr.115.011247","volume":"68","author":"B Mulloy","year":"2016","unstructured":"Mulloy, B., Hogwood, J., Gray, E., Lever, R. & Page, C. P. Pharmacology of heparin and related drugs. Pharmacol. Rev. 68, 76\u2013141 (2016).","journal-title":"Pharmacol. Rev."},{"key":"23466_CR57","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1002\/jcp.26075","volume":"233","author":"E Safarzadeh","year":"2018","unstructured":"Safarzadeh, E., Orangi, M., Mohammadi, H., Babaie, F. & Baradaran, B. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis. J. Cell Physiol. 233, 3024\u20133036 (2018).","journal-title":"J. Cell Physiol."},{"key":"23466_CR58","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","volume":"75","author":"SC Chafe","year":"2015","unstructured":"Chafe, S. C. et al. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. Cancer Res. 75, 996\u20131008 (2015).","journal-title":"Cancer Res."},{"key":"23466_CR59","doi-asserted-by":"publisher","first-page":"21248","DOI":"10.1073\/pnas.1015855107","volume":"107","author":"M Kowanetz","year":"2010","unstructured":"Kowanetz, M. et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl Acad. Sci. USA 107, 21248\u201321255 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23466_CR60","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1021\/acs.nanolett.8b01236","volume":"18","author":"H Cao","year":"2018","unstructured":"Cao, H. et al. Bioengineered macrophages can responsively transform into nanovesicles to target lung metastasis. Nano Lett. 18, 4762\u20134770 (2018).","journal-title":"Nano Lett."},{"key":"23466_CR61","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1039\/C8NR08936A","volume":"11","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Leukocyte-mimicking pluronic-lipid nanovesicle hybrids inhibit the growth and metastasis of breast cancer. Nanoscale 11, 5377\u20135394 (2019).","journal-title":"Nanoscale"},{"key":"23466_CR62","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","volume":"3","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran, S. E. et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: The AIO-FLOT3 Trial. JAMA Oncol. 3, 1237\u20131244 (2017).","journal-title":"JAMA Oncol."},{"key":"23466_CR63","doi-asserted-by":"publisher","first-page":"E7159","DOI":"10.1073\/pnas.1700455114","volume":"114","author":"YS Chang","year":"2017","unstructured":"Chang, Y. S., Jalgaonkar, S. P., Middleton, J. D. & Hai, T. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis. Proc. Natl Acad. Sci. USA 114, E7159\u2013e7168 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23466_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00000658-200007000-00009","volume":"232","author":"K Yamaguchi","year":"2000","unstructured":"Yamaguchi, K., Takagi, Y., Aoki, S., Futamura, M. & Saji, S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann. Surg. 232, 58\u201365 (2000).","journal-title":"Ann. Surg."},{"key":"23466_CR65","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1021\/acs.nanolett.9b00495","volume":"19","author":"T Jiang","year":"2019","unstructured":"Jiang, T. et al. Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression. Nano Lett. 19, 3548\u20133562 (2019).","journal-title":"Nano Lett."},{"key":"23466_CR66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P","volume":"190","author":"FW Orr","year":"2000","unstructured":"Orr, F. W., Wang, H. H., Lafrenie, R. M., Scherbarth, S. & Nance, D. M. Interactions between cancer cells and the endothelium in metastasis. J. Pathol. 190, 310\u2013329 (2000).","journal-title":"J. Pathol."},{"key":"23466_CR67","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/00001573-200211000-00005","volume":"17","author":"J Borja","year":"2002","unstructured":"Borja, J. Role of low-molecular-weight heparin in the management of acute coronary syndromes. Curr. Opin. Cardiol. 17, 608\u2013612 (2002).","journal-title":"Curr. Opin. Cardiol."},{"key":"23466_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","volume":"106","author":"IA Greer","year":"2005","unstructured":"Greer, I. A. & Nelson-Piercy, C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106, 401\u2013407 (2005).","journal-title":"Blood"},{"key":"23466_CR69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biopha.2016.02.032","volume":"79","author":"W Peng","year":"2016","unstructured":"Peng, W., Wu, J. & Feng, J. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma. Biomed. Pharmacother. 79, 188\u2013193 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"23466_CR70","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1065817","volume":"294","author":"S Saha","year":"2001","unstructured":"Saha, S. et al. A phosphatase associated with metastasis of colorectal cancer. Science 294, 1343\u20131346 (2001).","journal-title":"Science"},{"key":"23466_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","volume":"91","author":"H Maeda","year":"2015","unstructured":"Maeda, H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv. Drug Deliv. Rev. 91, 3\u20136 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"23466_CR72","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jps.1023","volume":"90","author":"T Lian","year":"2001","unstructured":"Lian, T. & Ho, R. J. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90, 667\u2013680 (2001).","journal-title":"J. Pharm. Sci."},{"key":"23466_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0169-409X(95)00039-A","volume":"17","author":"G Storm","year":"1995","unstructured":"Storm, G., Belliot, S. O., Daemen, T. & Lasic, D. D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. drug Deliv. Rev. 17, 31\u201348 (1995).","journal-title":"Adv. drug Deliv. Rev."},{"key":"23466_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000310762","volume":"211","author":"B Dick","year":"1997","unstructured":"Dick, B., Schmidt, K. G., Eisenmann, D. & Pfeiffer, N. A new method for direct detection of heparin on surface-modified intraocular lenses. A modification of Jaques\u2019 toluidine blue staining method. Ophthalmologica 211, 75\u201378 (1997).","journal-title":"Ophthalmologica"},{"key":"23466_CR75","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1021\/bm050007e","volume":"6","author":"CL Casper","year":"2005","unstructured":"Casper, C. L., Yamaguchi, N., Kiick, K. L. & Rabolt, J. F. Functionalizing electrospun fibers with biologically relevant macromolecules. Biomacromolecules 6, 1998\u20132007 (2005).","journal-title":"Biomacromolecules"},{"key":"23466_CR76","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/bio.2015.0026","volume":"13","author":"MT S\u00e1nchez-Fito","year":"2015","unstructured":"S\u00e1nchez-Fito, M. T. & Oltra, E. Optimized treatment of heparinized blood fractions to make them suitable for analysis. Biopreserv. Biobank 13, 287\u2013295 (2015).","journal-title":"Biopreserv. Biobank"},{"key":"23466_CR77","doi-asserted-by":"crossref","unstructured":"An, S. et al. Locally trapping the C-C chemokine receptor type 7 by gene delivery nanoparticle inhibits lymphatic metastasis prior to tumor resection. Small 15, e1805182 (2019).","DOI":"10.1002\/smll.201805182"},{"key":"23466_CR78","doi-asserted-by":"publisher","first-page":"345138","DOI":"10.1155\/2015\/345138","volume":"2015","author":"J Douxfils","year":"2015","unstructured":"Douxfils, J. et al. Non-VKA oral anticoagulants: accurate measurement of plasma drug concentrations. Biomed. Res. Int. 2015, 345138 (2015).","journal-title":"Biomed. Res. Int."},{"key":"23466_CR79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ajh.21718","volume":"85","author":"DD Castellone","year":"2010","unstructured":"Castellone, D. D. & Van Cott, E. M. Laboratory monitoring of new anticoagulants. Am. J. Hematol. 85, 185\u2013187 (2010).","journal-title":"Am. J. Hematol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23466-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T12:45:13Z","timestamp":1669985113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23466-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23466"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23466-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"30 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3187"}}